Table 2.
Characteristics of patients with COVID-19 (N=42) in the Emory Healthcare Virtual Outpatient Management Clinic between May 27 and August 24, 2020.
| Factor | Overall sample, n (%) | Hospitalized patients, n (%) | Nonhospitalized patients, n (%) | |||||
| Age (years) | ||||||||
|
|
<60 | 29 (69) | 14 (67) | 15 (71) | ||||
|
|
60-69 | 9 (21) | 5 (24) | 4 (19) | ||||
|
|
≥70 |
4 (10) | 2 (10) | 2 (10) | ||||
| Moderate risk factors | ||||||||
|
|
None | 5 (12) | 4 (19) | 1 (5) | ||||
|
|
1 | 23 (55) | 11 (52) | 11 (52) | ||||
|
|
2 | 7 (17) | 2 (10) | 5 (24) | ||||
|
|
≥3 | 8 (19) | 4 (19) | 4 (19) | ||||
| High risk factors (ie, cancer, cardiovascular disease, chronic kidney disease, and immunosuppression) | ||||||||
|
|
No | 23 (55) | 10 (48) | 13 (62) | ||||
|
|
Yes | 19 (45) | 11 (52) | 8 (38) | ||||
| Nonspecific symptoms | ||||||||
|
|
No | 7 (17) | 3 (14) | 4 (19) | ||||
|
|
Yes | 35 (83) | 18 (86) | 17 (81) | ||||
| Upper respiratory tract infection symptoms | ||||||||
|
|
No | 17 (41) | 8 (38) | 9 (43) | ||||
|
|
Yes | 25 (60) | 13 (62) | 12 (57) | ||||
| Lower respiratory tract infection symptoms | ||||||||
|
|
None | 4 (10) | 2 (10) | 2 (10) | ||||
|
|
Minor cough | 15 (36) | 7 (33) | 8 (38) | ||||
|
|
Other (ie, chest tightness or dyspnea on exertion) | 23 (55) | 12 (57) | 11 (52) | ||||
| Mental health symptoms | ||||||||
|
|
No | 37 (88) | 18 (86) | 19 (91) | ||||
|
|
Yes | 5 (12) | 3 (14) | 2 (10) | ||||
| Symptom severity | ||||||||
|
|
Mild | 26 (62) | 12 (57) | 14 (67) | ||||
|
|
Moderate | 13 (31) | 9 (43) | 4 (19) | ||||
|
|
Severe | 2 (5) | 0 (0) | 2 (10) | ||||
|
|
N/Aa | 1 (2) | 0 (0) | 1 (5) | ||||
| Symptom day | ||||||||
|
|
1-6 | 19 (45) | 10 (48) | 9 (43) | ||||
|
|
15-21 | 10 (24) | 5 (24) | 5 (24) | ||||
|
|
7-14 | 12 (29) | 6 (29) | 6 (29) | ||||
|
|
N/A | 1 (2) | 0 (0) | 1 (5) | ||||
| Symptom course days 1-6 | ||||||||
|
|
Days 1-6 | |||||||
|
|
|
Improving | 6 (32) | 3 (30) | 3 (33) | |||
|
|
|
Stable | 10 (53) | 7 (70) | 3 (33) | |||
|
|
|
Worsening | 3 (16) | 0 (0) | 3 (33) | |||
|
|
Days 7-14 | |||||||
|
|
|
Improving | 2 (17) | 0 (0) | 2 (33) | |||
|
|
|
Stable | 7 (58) | 3 (50) | 4 (67) | |||
|
|
|
Worsening | 3 (25) | 3 (50) | 0 (0) | |||
|
|
Days 15-21 | |||||||
|
|
|
Improving | 5 (50) | 1 (20) | 4 (80) | |||
|
|
|
Stable | 5 (50) | 4 (80) | 1 (20) | |||
|
|
|
Worsening | 0 (0) | 0 (0) | 0 (0) | |||
|
|
Day 22 and beyond | |||||||
|
|
|
N/A | 42 (100) | 21 (100) | 21 (100) | |||
aN/A: not applicable.